login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
SOPHIA GENETICS SA (SOPH) Stock News
USA
- NASDAQ:SOPH -
CH1125843347
-
Common Stock
4.09
USD
-0.11 (-2.62%)
Last: 10/28/2025, 8:22:40 PM
4.08
USD
-0.01 (-0.24%)
Pre-Market:
10/29/2025, 5:04:17 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SOPH Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Sophia Genetics
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
9 days ago - By: Zacks Investment Research
- Mentions:
TXG
TEM
Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?
12 days ago - By: Sophia Genetics
A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben
12 days ago - By: Sophia Genetics
A.D.A.M. Innovations et SOPHiA GENETICS s'associent pour faire progresser les tests de biopsie liquide et les diagnostics compagnons pour l'oncologie de précision au Japon
12 days ago - By: Sophia Genetics
A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan
3 months ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
6 months ago - By: Benzinga
- Mentions:
ENLT
SSL
ATKR
GPOR
...
Earnings Scheduled For May 6, 2025
13 days ago - By: Sophia Genetics
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
13 days ago - By: Sophia Genetics
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
a month ago - By: Sophia Genetics
- Mentions:
MYGN
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
a month ago - By: Myriad Genetics, Inc.
- Mentions:
MYGN
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
a month ago - By: Sophia Genetics
- Mentions:
AZN
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
2 months ago - By: Sophia Genetics
SOPHiA GENETICS en Jessa Ziekenhuis kondigen samenwerking aan op het gebied van precisieoncologie tijdens het European Congress of Pathology
2 months ago - By: Sophia Genetics
SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie
2 months ago - By: Sophia Genetics
SOPHiA GENETICS et Jessa Ziekenhuis annoncent un partenariat en oncologie de précision au Congrès européen de pathologie
2 months ago - By: Sophia Genetics
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
2 months ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
TEM
Strategic Partnerships Power Tempus AI's Healthcare Expansion
3 months ago - By: Zacks Investment Research
- Mentions:
IRTC
TEM
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
3 months ago - By: Sophia Genetics
SOPHiA GENETICS Reports Second Quarter 2025 Results
3 months ago - By: Sophia Genetics
- Mentions:
AZN
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
6 months ago - By: Zacks Investment Research
- Mentions:
AZN
IRTC
TEM
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
6 months ago - By: Zacks Investment Research
- Mentions:
CTEV
SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Sophia Genetics
SOPHiA GENETICS Reports First Quarter 2025 Results
6 months ago - By: Zacks Investment Research
- Mentions:
TXG
TEM
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?
6 months ago - By: Sophia Genetics
- Mentions:
AZN
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
6 months ago - By: Zacks Investment Research
- Mentions:
AZN
IRTC
TEM
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS
6 months ago - By: Zacks Investment Research
- Mentions:
AZN
IRTC
TEM
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
6 months ago - By: Sophia Genetics
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025
7 months ago - By: Precision for Medicine
Precision for Medicine s'associe à SOPHiA GENETICS pour étendre ses services biopharmaceutiques avec la plateforme SOPHiA DDM™ et ses capacités de biopsie liquide
7 months ago - By: Precision for Medicine
Precision for Medicine geht mit SOPHiA GENETICS eine Partnerschaft ein, um seine Biopharma-Dienstleistungen mit der SOPHiA DDM™-Plattform und ihren Liquid-Biopsy-Funktionen zu erweitern
7 months ago - By: Precision for Medicine
Precision for Medicine se asocia con SOPHiA GENETICS para ampliar los servicios biofarmacéuticos
Please enable JavaScript to continue using this application.